Skip to main content

Table 1 Baseline characteristics and perioperative outcomes of 95 patients with stage 0-III rectal cancer undergoing robotic-assisted total mesorectal excision

From: Robotic-assisted total mesorectal excision with the single-docking technique for patients with rectal cancer

Characteristic  
Age (years, median) (range) 62 (28–88)
Gender
 Female 35 (36.8%)
 Male 60 (63.2%)
Tumor distance from anal verge (cm)
 5 (Lower) 48 (50.5%)
 6–10 (Middle) 30 (31.6%)
 11–15 (Upper) 17 (17.9%)
Distance from anal verge (cm, median) (range) 5.5 (1–15)
Pre-operation CCRT
 Yes 75 (78.9%)
 No 20 (21.1%)
Pre-operation chemotherapy regimen 75
 FOLFOX 58 (77.3%)
 Fluoropyrimidine-based 17 (22.7%)
Time interval between radiotherapy completion and robotic surgery (day, median) (range) (75 patients undergoing pre-operation chemotherapy) 82 (41–203)
ASA classification
 II 52 (54.7%)
 III 43 (45.3%)
BMI kg/m2 (Median) (range) 23.54 (17.20–34.02)
Procedure
 LAR 59 (62.1%)
 ISR 32 (33.7%) (including 3 transabdominal ISR)
 APR 4 (4.2%)
Protective Diverting Colostomy
 Yes 38 (40.0%)
 No 57 (60.0%)
Docking Time (min, median) (range) 5 (3–22)
Console Time (min, median) (range) 200 (130–435)
Operation Time (min, median) (range) 325 (210–795)
Estimated blood loss (mL, Median) 80 (15–1050)
Time of first flatus passage (day) (Median, range) 2 (1–10)
Time of resuming soft diet (day) (Median, range) 4 (2–15)
Postoperative hospital stay (day) (Median, range) 6 (5–32)
Postoperative first day VAS pain score (Median, range) 3 (1–8)
  1. APR abdominoperineal resection, AR anterior resection, ASA American Society of Anesthesiologists, BMI Body mass index, CCRT Concurrent chemoradiotherapy, ISR, intersphenteric resection, LAR low anterior resection, VAS visual analog scale